It may be true that beauty is in the eye of the beholder, which makes beauty a matter of debate. There is no objective standard for beauty. What an individual sees as beauty is actually a matter of taste or opinion. However, whether or not a suspicious mass of tissue is seen as prostate cancer keep reading

If your PSA is unusually high or your digital rectal exam finds an abnormality, how do you know if it’s prostate cancer? Magnetic resonance imaging (MRI) is now the universally preferred noninvasive method for identifying prostate cancer (PCa) prior to having a biopsy. In the years leading up to this, researchers worked toward agreement over keep reading

If you ever adopted a male puppy, at the first vet visit you might have gotten this suggestion: “You should neuter your puppy to prevent prostate cancer.” There are, of course, two other common reasons why dog owners consider this surgery. The first is to avoid unwanted breeding (the owners of female dogs that are keep reading

For at least two decades, patient advocacy groups have pushed to increase awareness for men with a family history of prostate cancer (PCa). The most important fact is that men whose father or brother had PCa are more that twice as likely to develop the disease themselves. In addition, we now know that men who keep reading

Curiosity is, well, a curious thing. The philosopher Thomas Hobbes dubbed it “the lust of the mind.” After all, from birth onward the brain has a constant appetite to know stuff. In a New Science article, science writer Dan Jones states, “Curiosity is the driving force behind science, exploration and discovery.” It may occur as keep reading

A few years ago I posted a blog on two published studies connecting the humble anti-inflammatory drug aspirin with less likelihood of prostate cancer recurrence among high-risk patients. The evidence of reduced PCa-specific mortality among high-risk patients who took daily aspirin was clear both. However, the exact mechanism by which aspirin may prevent the formation, progression, and metastasis of certain types of cancer cells was not fully understood.... keep reading

Because of my interest in immunotherapy, especially in conjunction with focal treatment of prostate cancer, I investigated claims that naltrexone (a drug approved for treatment of alcohol or opioid1 dependency) can normalize the immune system when taken in subtherapeutic (low) doses. keep reading

Would you go over Niagara Falls in a barrel? Get shot out of a circus cannon? Jump a motorcycle over 19 cars? No, because obviously the calculated risks are absurdly high. However, how do you calculate the risks of treatment when it comes to prostate cancer (PCa)? After all, every approach carries some risk of keep reading

The latest update on HPV (human papillomavirus or genital warts) concerns HPV as a potential cause of prostate cancer (PCa) based on detecting the DNA of the virus in blood samples. The authors of a 2023 paper detected the presence of the HPV virus in some men with prostate cancer (PCa) vs. a control group without PCa. keep reading

It’s no secret: “Erectile dysfunction (ED) is a common problem after prostate cancer treatment despite innovations to minimise the risk of side-effects.”[i] That’s a common opening statement in a slew of journal articles, and they all contain the phrase “prostate cancer treatment.” For the most part, what they’re really talking about is radical prostatectomy (RP), keep reading